![Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife](https://iiif.elifesciences.org/lax/72919%2Felife-72919-fig7-v2.tif/full/1500,/0/default.jpg)
Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes | eLife
![Glucagon Represses Signaling through the Mammalian Target of Rapamycin in Rat Liver by Activating AMP-activated Protein Kinase* - Journal of Biological Chemistry Glucagon Represses Signaling through the Mammalian Target of Rapamycin in Rat Liver by Activating AMP-activated Protein Kinase* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0b0e01d6-964b-488a-bf61-646f85f245b5/gr6_lrg.jpg)
Glucagon Represses Signaling through the Mammalian Target of Rapamycin in Rat Liver by Activating AMP-activated Protein Kinase* - Journal of Biological Chemistry
![Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists - Li - 2020 - Diabetes, Obesity and Metabolism - Wiley Online Library Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists - Li - 2020 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/8fa54f5f-524b-40f5-a5f2-bab266bd302c/dom14173-fig-0006-m.jpg)
Amino acids are sensitive glucagon receptor‐specific biomarkers for glucagon‐like peptide‐1 receptor/glucagon receptor dual agonists - Li - 2020 - Diabetes, Obesity and Metabolism - Wiley Online Library
![GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances](https://www.science.org/cms/10.1126/sciadv.abf1948/asset/d06eccd3-1518-43a8-83e0-03a9c90969c0/assets/graphic/abf1948-f1.jpeg)
GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells | Science Advances
![Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124720307415-fx1.jpg)
Vitamin-D-Binding Protein Contributes to the Maintenance of α Cell Function and Glucagon Secretion - ScienceDirect
![PDF) Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells PDF) Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells](https://i1.rgstatic.net/publication/358377499_Glucagon_signaling_via_supraphysiologic_GCGR_can_reduce_cell_viability_without_stimulating_gluconeogenic_gene_expression_in_liver_cancer_cells/links/61ff38ba702c892cef0909e8/largepreview.png)
PDF) Glucagon signaling via supraphysiologic GCGR can reduce cell viability without stimulating gluconeogenic gene expression in liver cancer cells
![Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation | SpringerLink Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-022-05729-y/MediaObjects/125_2022_5729_Fig5_HTML.png)
Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation | SpringerLink
![Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News](https://images.jems.com/wp-content/uploads/2018/08/1808JEMSkah-p01-Eli-Lilly-Glucagon.png)
Expanding Glucagon Access and Use in the Prehospital Setting - JEMS: EMS, Emergency Medical Services - Training, Paramedic, EMT News
![Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by γ-Hydroxybutyrate and Glycine* - Journal of Biological Chemistry Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by γ-Hydroxybutyrate and Glycine* - Journal of Biological Chemistry](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6c1829ae-52f9-4eeb-a167-de9db1df446f/gr7_lrg.jpg)
Regulation of Glucagon Secretion in Normal and Diabetic Human Islets by γ-Hydroxybutyrate and Glycine* - Journal of Biological Chemistry
![Metro Della Glicemia, Penna Dell'insulina E Glucagone Immagine Stock - Immagine di infezioni, digitale: 50998269 Metro Della Glicemia, Penna Dell'insulina E Glucagone Immagine Stock - Immagine di infezioni, digitale: 50998269](https://thumbs.dreamstime.com/b/metro-della-glicemia-penna-dell-insulina-e-glucagone-50998269.jpg)
Metro Della Glicemia, Penna Dell'insulina E Glucagone Immagine Stock - Immagine di infezioni, digitale: 50998269
![Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3 | Scientific Reports Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3 | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-00210-y/MediaObjects/41598_2017_210_Fig1_HTML.jpg)
Lysophosphatidic acid counteracts glucagon-induced hepatocyte glucose production via STAT3 | Scientific Reports
![Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation | SpringerLink Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-022-05729-y/MediaObjects/125_2022_5729_Figa_HTML.png)